Skip to content
Search

Latest Stories

PDA to inform its members to vote “no” in Royal College of Pharmacy proposals

Swizzels’ Easter range, including Squashies Drumchick and Sweet Shop Favourite tubs

PDA members will get the chance to vote from this week

Pic credit: iStock

A vote to create a potential Royal College of Pharmacy needs to be called off as the current proposals would lead to “irreversible change to the identity and purpose” of the sector’s professional leadership body, according to the Pharmacy Defence Association (PDA).

From March 13th to March 24th, The Royal Pharmaceutical Society’s members will take part in a Special Resolution Vote (SRV) which seeks to amend the Society’s Royal Charter to facilitate its transition to a Royal College and registered charity.


This significant step, which came following an 18-month independent review of the RPS constitution and governance, aims to strengthen the RPS’s leadership role, with the ultimate goal of delivering greater benefits to patients and the public.

However, the PDA has warned that it will advise its members to vote ‘no’ as the current proposals will "change the very nature of why the RPS was set up".

“The proposed changes, by their very nature, will not only affect current RPS members, but will impact upon the practicing landscape of all pharmacists,” the PDA said in a statement.

“The PDA believes that to legitimise any such proposed change, the RPS must first raise awareness of the proposals to a far greater extent amongst pharmacists and allow them to have an informed debate as well as to enable them to consider alternative options.

“It should also deal with the concerns being expressed. Above all, it should not be trying to rush through a hastily convened ballot which commences on March 13th.”

The PDA carried out a survey which involved just over 2000 pharmacists, a mixture of both RPS and non RPS members, to garner widespread opinion on the proposals.

It said the results demonstrate that the levels of awareness on this important issue are nowhere near adequate to justify the holding of the ballot at this time as 67 per cent of respondents said they felt “not very well” or “not at all” informed about the proposals.

The PDA revealed it had met with the senior leadership of the RPS on two separate occasions but said it had not emerged from these meetings with a “full understanding of the RPS’s vision for the future, nor how they saw themselves working collaboratively alongside other organisations in the pharmacy ecosystem for the wider benefit of all pharmacists”.

“The RPS proposals involved changing the RPS into a charity whose principal objective would be to act in the public interest. The previous objective to safeguard, maintain the honour, and promote the interests of pharmacists, would be lost,” said the PDA.

More For You

Walgreens Boots Alliance acquired by Sycamore in deal

Walgreens Boots Alliancehas entered into “a definitive agreement” to be acquired by Sycamore Partners

Gettyimages

Walgreens Boots Alliance acquired by Sycamore in £18.3 billion deal

Walgreens Boots Alliance(WBA) has entered into “a definitive agreement” to be acquired by Sycamore Partners, a private equity firm specializing in retail, consumer and distribution-related investments.

“The total value of the transaction represents up to $23.7 billion (£18.3 billion),” the company announced late last night (6).

Keep ReadingShow less
Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Lawrence Tallon named new MHRA chief executive

Lawrence Tallon

Photo credit: Sciana Network

Lawrence Tallon named new MHRA chief executive

Lawrence Tallon has been appointed as the new chief executive officer of the Medicines and Healthcare products Regulatory Agency (MHRA), effective 1 April 2025.

He will succeed Dame June Raine DBE, who is retiring after leading the agency since 2019.

Keep ReadingShow less